Top

Gepubliceerd in:

29-07-2019

Impact of pharmaceutical care on mental well-being and perceived health among community-dwelling individuals with type 2 diabetes

Auteurs: Zheng Kang Lum, Melanie Yee Lee Siaw, Michelle Jia Xin Lee, Zexuan Koh, Parry Quan Zhang, Soo Kiang Eng, Swee Chin Tan, Joyce Yu-Chia Lee

Gepubliceerd in: Quality of Life Research | Uitgave 12/2019

Abstract

Purpose

Mental well-being among community-dwelling individuals with type 2 diabetes has not been well established. The primary objective was to evaluate the change in the mental well-being of individuals with diabetes. The secondary objective was to evaluate the association between changes in mental well-being and perceived health over 6 months, and any interacting factors in this association.

Methods

This was a prospective, multicenter study. Community-dwelling individuals aged ≥ 21 years with type 2 diabetes were invited to meet with community pharmacists monthly for 6 months. Individuals who were unable to converse independently were excluded. A 12-item General Health Questionnaire (GHQ), measuring mental well-being was administered at baseline, and after 3 and 6 months. Perception of health was measured using the visual analog scale (VAS) of the EuroQoL 5-Dimension tool. Linear mixed model was used to analyze the change in mean GHQ and VAS scores. Association between the changes in GHQ and VAS scores was determined, and moderation analysis was conducted to elucidate the interacting variables of this association.

Results

Ninety-six individuals (82.4%) were included for analysis. The mean age was 60.3 years with a baseline mean HbA1c of 7.6%. A mean GHQ score reduction of 1.36 (p = 0.022) was observed. This reduction of mean GHQ score was associated with the change in mean VAS score. Having a duration of diabetes diagnosis of < 3.2 years was identified as moderator of this association.

Conclusion

Effective integrated pharmaceutical care with individualized counseling on lifestyle management appeared to improve the mental health of community-dwelling individuals with diabetes on top of glycemic control.

vorige artikel Increasing exercise frequency is associated with health and quality-of-life benefits for older adults

volgende artikel Exploring health-related quality of life of Spanish domestic adult adoptees: sociodemographic characteristics, chronic medical conditions, and gender differences

Hepler, C. D., & Strand, L. M. (1990). Opportunities and responsibilities in pharmaceutical care. American Journal of Health-System Pharmacy,47, 533–543.CrossRef

McAllister, M., Dunn, G., Payne, K., et al. (2012). Patient empowerment: The need to consider it as a measurable patient-reported outcome for chronic conditions. BMC Health Services Research,12, 157. https://doi.org/10.1186/1472-6963-12-157.CrossRefPubMedPubMedCentral

Blackburn, D. F., Yakiwchuk, E. M., Jorgenson, D. J., & Mansell, K. D. (2012). Proposing a redefinition of pharmaceutical care. Annals of Pharmacotherapy,46, 447–449. https://doi.org/10.1345/aph.1Q585.CrossRefPubMed

Carollo, A., Rieutord, A., Launay-Vacher, V., & European Society of Clinical Pharmacy. (2012). European Society of Clinical Pharmacy (ESCP) glossary of scientific terms: A tool for standardizing scientific jargon. International Journal of Clinical Pharmacy,34, 263–268. https://doi.org/10.1007/s11096-012-9619-1.CrossRefPubMed

Awad, A., Al-Ebrahim, S., & Abahussain, E. (2006). Pharmaceutical care services in hospitals of Kuwait. Journal of Pharmacy & Pharmaceutical Sciences,9, 149–157.

Brulhart, M. I., & Wermeille, J. P. (2011). Multidisciplinary medication review: Evaluation of a pharmaceutical care model for nursing homes. International Journal of Clinical Pharmacy,33, 549–557. https://doi.org/10.1007/s11096-011-9506-1.CrossRefPubMed

Geurts, M. M. E., Stewart, R. E., Brouwers, J. R. B. J., et al. (2016). Implications of a clinical medication review and a pharmaceutical care plan of polypharmacy patients with a cardiovascular disorder. International Journal of Clinical Pharmacy,38, 808–815. https://doi.org/10.1007/s11096-016-0281-x.CrossRefPubMedPubMedCentral

Finkers, F., Maring, J. G., Boersma, F., & Taxis, K. (2007). A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting. Journal of Clinical Pharmacy and Therapeutics,32, 469–476. https://doi.org/10.1111/j.1365-2710.2007.00849.x.CrossRefPubMed

Zaman Huri, H., & Chai Ling, L. (2013). Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia. BMC Public Health,13, 1192. https://doi.org/10.1186/1471-2458-13-1192.CrossRefPubMedPubMedCentral

10.

García-Pérez, L.-E., Alvarez, M., Dilla, T., et al. (2013). Adherence to therapies in patients with type 2 diabetes. Diabetes Therapy, Research, Treatment and Education of Diabetes and Related Disorders,4, 175–194. https://doi.org/10.1007/s13300-013-0034-y.CrossRef

11.

Wong, E. L., Yam, C. H., Cheung, A. W., et al. (2011). Barriers to effective discharge planning: A qualitative study investigating the perspectives of frontline healthcare professionals. BMC Health Services Research,11, 242. https://doi.org/10.1186/1472-6963-11-242.CrossRefPubMedPubMedCentral

12.

Jacobs, B., Ir, P., Bigdeli, M., et al. (2012). Addressing access barriers to health services: An analytical framework for selecting appropriate interventions in low-income Asian countries. Health Policy Plan,27, 288–300. https://doi.org/10.1093/heapol/czr038.CrossRefPubMed

13.

Fonseca, V. A. (2009). Defining and characterizing the progression of type 2 diabetes. Diabetes Care,32(Suppl 2), S151–S156. https://doi.org/10.2337/dc09-S301.CrossRefPubMedPubMedCentral

14.

Machado, M., Bajcar, J., Guzzo, G. C., & Einarson, T. R. (2007). Sensitivity of patient outcomes to pharmacist interventions. Part I: Systematic review and meta-analysis in diabetes management. Annals of Pharmacotherapy,41, 1569–1582. https://doi.org/10.1345/aph.1K151.CrossRefPubMed

15.

Ali, M., Schifano, F., Robinson, P., et al. (2012). Impact of community pharmacy diabetes monitoring and education programme on diabetes management: A randomized controlled study. Diabetic Medicine,29, e326–e333. https://doi.org/10.1111/j.1464-5491.2012.03725.x.CrossRefPubMed

16.

Mossialos, E., Courtin, E., Naci, H., et al. (2015). From “retailers” to health care providers: Transforming the role of community pharmacists in chronic disease management. Health Policy,119, 628–639. https://doi.org/10.1016/j.healthpol.2015.02.007.CrossRefPubMed

17.

Dhippayom, T., & Krass, I. (2015). Supporting self-management of type 2 diabetes: Is there a role for the community pharmacist? Patient Preference and Adherence,9, 1085–1092. https://doi.org/10.2147/PPA.S88071.CrossRefPubMedPubMedCentral

18.

Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review,84, 191–215.CrossRef

19.

Walker, R. J., Smalls, B. L., Hernandez-Tejada, M. A., et al. (2014). Effect of diabetes self-efficacy on glycemic control, medication adherence, self-care behaviors, and quality of life in a predominantly low-income, minority population. Ethnicity and Disease,24, 349–355.PubMed

20.

Indelicato, L., Dauriz, M., Santi, L., et al. (2017). Psychological distress, self-efficacy and glycemic control in type 2 diabetes. Nutrition, Metabolism and Cardiovascular Diseases,27, 300–306. https://doi.org/10.1016/j.numecd.2017.01.006.CrossRefPubMed

21.

Perrin, N. E., Davies, M. J., Robertson, N., et al. (2017). The prevalence of diabetes-specific emotional distress in people with Type 2 diabetes: A systematic review and meta-analysis. Diabetic Medicine,34, 1508–1520. https://doi.org/10.1111/dme.13448.CrossRefPubMed

22.

Wändell, P. E. (2005). Quality of life of patients with diabetes mellitus. An overview of research in primary health care in the Nordic countries. Scandinavian Journal of Primary Health Care,23, 68–74. https://doi.org/10.1080/02813430510015296.CrossRefPubMed

23.

Dismuke, C. E., Hernandez-Tejada, M. A., & Egede, L. E. (2014). Relationship of serious psychological distress to quality of life in adults with diabetes. International Journal of Psychiatry in Medicine,48, 135–146. https://doi.org/10.2190/PM.48.2.f.CrossRefPubMed

24.

Donald, M., Dower, J., Coll, J. R., et al. (2013). Mental health issues decrease diabetes-specific quality of life independent of glycaemic control and complications: Findings from Australia’s living with diabetes cohort study. Health and Quality of Life Outcomes,11, 170. https://doi.org/10.1186/1477-7525-11-170.CrossRefPubMedPubMedCentral

25.

NCD Risk Factor Collaboration (NCD-RisC). (2016). Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants. The Lancet London England,387, 1513–1530. https://doi.org/10.1016/S0140-6736(16)00618-8.CrossRef

26.

Lim, R. B. T., Zheng, H., Yang, Q., et al. (2013). Ethnic and gender specific life expectancies of the Singapore population, 1965 to 2009—converging, or diverging? BMC Public Health,13, 1012. https://doi.org/10.1186/1471-2458-13-1012.CrossRefPubMedPubMedCentral

27.

Mulimba, A. A. C., & Byron-Daniel, J. (2014). Motivational interviewing-based interventions and diabetes mellitus. British Journal of Nursing,23, 8–14.CrossRef

28.

Motivational Interviewing: Empowering Patients to Change Behaviors. Retrieved March 18, 2018, from http://elearning.pharmacist.com/products/4313/motivational-interviewing-empowering-patients-to-change-behaviors.

29.

Goldberg, D. P., Gater, R., Sartorius, N., et al. (1997). The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychological Medicine,27, 191–197.CrossRef

30.

Luo, N., Chew, L. H., Fong, K. Y., et al. (2003). Validity and reliability of the EQ-5D self-report questionnaire in English-speaking Asian patients with rheumatic diseases in Singapore. Quality of Life Research,12, 87–92.CrossRef

31.

Hayes, A. F. (2013). Introduction to mediation, moderation and conditional process analysis: A regression based approach. New York: Guilford Press.

32.

Co, M. A., Tan, L. S. M., Tai, E. S., et al. (2015). Factors associated with psychological distress, behavioral impact and health-related quality of life among patients with type 2 diabetes mellitus. Journal of Diabetes and Its Complications,29, 378–383. https://doi.org/10.1016/j.jdiacomp.2015.01.009.CrossRefPubMed

33.

Pereira, M. G., Pedras, S., Ferreira, G., & Machado, J. C. (2018). Differences, predictors, and moderators of therapeutic adherence in patients recently diagnosed with type 2 diabetes. Journal of Health Psychology. https://doi.org/10.1177/1359105318780505.CrossRefPubMed

34.

Hayes, A. F., & Montoya, A. K. (2017). A tutorial on testing, visualizing, and probing an interaction involving a multicategorical variable in linear regression analysis. Communication Methods and Measures,11, 1–30. https://doi.org/10.1080/19312458.2016.1271116.CrossRef

35.

Chew, B.-H., Vos, R., Mohd-Sidik, S., & Rutten, G. E. H. M. (2016). Diabetes-related distress, depression and distress-depression among adults with type 2 diabetes mellitus in Malaysia. PLoS ONE,11, e0152095. https://doi.org/10.1371/journal.pone.0152095.CrossRefPubMedPubMedCentral

36.

Rothman, R., Malone, R., Bryant, B., et al. (2003). Pharmacist-led, primary care-based disease management improves hemoglobin A1c in high-risk patients with diabetes. American Journal of Medical Quality,18, 51–58. https://doi.org/10.1177/106286060301800202.CrossRefPubMed

37.

Armour, C. L., Taylor, S. J., Hourihan, F., et al. (2004). Implementation and evaluation of Australian pharmacists’ diabetes care services. Journal of the American Pharmacists Association,44, 455–466.CrossRef

38.

Lange, L. J., & Piette, J. D. (2005). Perceived health status and perceived diabetes control: Psychological indicators and accuracy. Journal of Psychosomatic Research,58, 129–137. https://doi.org/10.1016/j.jpsychores.2004.08.004.CrossRefPubMed

39.

Livneh, H., & Antonak, R. F. (2005). Psychosocial adaptation to chronic illness and disability: A primer for counselors. Journal of Counseling & Development,83, 12–20. https://doi.org/10.1002/j.1556-6678.2005.tb00575.x.CrossRef

40.

Al-Amer, R., Ramjan, L., Glew, P., & Salamonson, Y. (2015). Diagnosis of type 2 diabetes: The experience of Jordanian patients with co-existing depression. Issues in Mental Health Nursing,36, 231–238. https://doi.org/10.3109/01612840.2014.960627.CrossRefPubMed

41.

American Diabetes Association. (2018). Standards of medical care in diabetes—2018. Diabetes Care,41(Suppl. 1), S1–S159.

42.

Harris, A. D., McGregor, J. C., Perencevich, E. N., et al. (2006). The use and interpretation of quasi-experimental studies in medical informatics. Journal of the American Medical Informatics Association JAMIA,13, 16–23. https://doi.org/10.1197/jamia.M1749.CrossRefPubMedPubMedCentral

43.

Geppert, C., Candilis, P., Baker, S., et al. (2014). Motivations of patients with diabetes to participate in research. AJOB Empirical Bioethics,5, 14–21. https://doi.org/10.1080/23294515.2014.910282.CrossRefPubMedPubMedCentral

Titel: Impact of pharmaceutical care on mental well-being and perceived health among community-dwelling individuals with type 2 diabetes
Auteurs: Zheng Kang Lum
Melanie Yee Lee Siaw
Michelle Jia Xin Lee
Zexuan Koh
Parry Quan Zhang
Soo Kiang Eng
Swee Chin Tan
Joyce Yu-Chia Lee
Publicatiedatum: 29-07-2019
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 12/2019
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-019-02253-2

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusion

Log in om toegang te krijgen

Andere artikelen Uitgave 12/2019

Viewing assessments of patient-reported heath status as conversations: Implications for developing and evaluating patient-reported outcome measures

A psychometric analysis and revalidation of the Yale-Brown Obsessive Compulsive Scale modified for Binge Eating in adults with binge eating disorder

Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophrenia

German value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30

Psychometric properties of the PROMIS® Fatigue Short Form 7a among adults with myalgic encephalomyelitis/chronic fatigue syndrome

A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set